Abstract
Myocardial infarction, the most common complication of atherosclerosis, remains a deadly disease. According to an international survey done between 1985 and 1990 [1], median 4-week mortality of acute coronary heart disease reaches the bewildering rate of 50%. Beyond treatment, prevention is clearly a major issue and any progress in our understanding of atherosclerosis can have a wide impact on public health. Inflammation is now ranking high among current explanations, with the possibility of infection as one of its potential causes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Chambless L, Keil U, Dobson A, et al. (1997) Population versus clinical view of case fatality from acute coronary heart disease: Results from the WHO MONICA Project 1985–1990. Circulation 96:3849–3859
Capron L (1987) Cause de l’athérosclérose: l’hypothèse virale. Arch Mal Coeur 80 (suppl.I):51–55
Virchow R (1862) Phlogose und Thrombose im Gefässystem. In: Gesammelte Abhandlungen zur wissenschaftlichen Medizin. Max Hirsch, Berlin
Capron L (1993) Mécanismes inflammatoires de l’athérosclérose: inférences pathogéniques et étiologiques. Arch Mal Coeur 86(suppl.I):19–30
Jonasson L, Holm J, Skalli O, Bondjers G, Hansson GK (1986) Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis 6:131–138
Kragel AH, Reddy SG, Wittes JT, Roberts WC (1989) Morphometric analysis of the composition of atherosclerotic plaques in the four major epicardial coronary arteries in acute myocardial infarction and in sudden coronary death. Circulation 80:1747–1756
Rekhter MD, Gordon D (1995) Active proliferation of different cell types, including lymphocytes, in human atherosclerotic plaques. Am J Pathol 147:668–677
Zhang Y, Cliff WJ, Schoefl GI, Higgins G (1993) Immunohistochemical study of intimal microvessels in coronary atherosclerosis. Am J Pathol 143:164–172
Capron L (1996) Évolution des théories sur l’athérosclérose. Rev Prat (Paris) 46:533–537
Huchard H (1891) Les causes de l’artério-sclérose et des cardiopathies artérielles. Rev Gén Clin Thérap 5:637–639
Vallance P, Collier J, Bhagat K (1997) Infection, inflammation, and infarction: does acute endothelial dysfunction provide a link? Lancet 349:1391–1392
Wick G, Schett G, Amberger A, Kleindienst R, Xu QB (1995) Is atherosclerosis an immunologically mediated disease? Immunol Today 16:27–33
Capron L (1996) Chlamydia in coronary plaques — Hidden culprit or harmless hobo? Nature Med 2:856–857
Danesh J, Collins R, Peto R (1997) Chronic infections and coronary heart disease: is there a link? Lancet 350:430–436
Fabricant CG, Fabricant J, Litrenta MM, Minick CR (1978) Virus-induced atherosclerosis. J Exp Med 148:335–340
Nicholson AC, Hajjar DP (1998) Herpesviruses in atherosclerosis and thrombosis: Etiologic agents or ubiquitous bystanders? Arterioscler Thromb Vasc Biol 18:339–348
Hendrix MGR, Salimans MMM, Vanboven CPA, Bruggeman CA (1990) High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade-III atherosclerosis. Am J Pathol 136:23–28
Gag SZ, Hunt SA, Schroeder JS, Alderman EL, Hill IR, Stinson EB (1996) Early development of accelerated graft coronary artery disease: Risk factors and course. J Am Coll Cardiol 28:673–679
Wu TC, Hruban RH, Ambinder RF, et al. (1992) Demonstration of cytomegalovirus nucleic acids in the coronary arteries of transplanted hearts. Am J Pathol 140:739–747
Gulizia JM, Kandolf R, Kendall TJ, et al. (1995) Infrequency of cytomegalovirus genome in coronary arteriopathy of human heart allografts. Am J Pathol 147:461–475
Zhou YF, Leon MB, Waclawiw MA, et al. (1996) Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N Engl J Med 335:624–630
Speir E, Modali R, Huang ES, et al. (1994) Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 265:391–394
Blum A, Giladi M, Weinberg M, et al. (1998) High anti-cytomegalovirus (CMV) IgG antibody titer is associated with coronary artery disease and may predict post-coronary balloon angioplasty restenosis. Am J Cardiol 81:866–868
Carlsson J, Miketic S, Mueller KH, et al. (1997 & 1998) Previous cytomegalovirus or Chlamydia pneumoniae infection and risk of restenosis after percutaneous transluminal coronary angioplasty. Lancet 350:1225 & 351:143 [letters].
Legrand A, Mayer EP, Dalvi SS, Nachtigal M (1997) Transformation of rabbit vascular smooth muscle cells by human cytomegalovirus morphological transforming region 1. Am J Pathol 151:1387–1395
Grayston JT, Kuo CC, Wang SP, Altman J (1986) A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory track infections. N Engl J Med 315:161–168
Kuo CC, Jackson LA, Campbell LA, Grayston JT (1995) Chlamydia pneumoniae (TWAR). Clin Microbiol Rev 8:451–461
Saikku P, Leinonen M, Mattila K, et al. (1988) Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet ii:983–985
Moazed TC, Kuo CC, Patton DL, Grayston JT, Campbell LA (1996) Experimental rabbit models of Chlamydia pneumoniae infection. Am J Pathol 148:667–676
Moazed TC, Kuo CC, Grayston JT, Campbell LA (1997) Murine models of Chlamydia pneumoniae infection and atherosclerosis. J Infect Dis 175:883–890
Gaydos CA, Summersgill JT, Sahney NN, Ramirez JA, Quinn TC (1996) Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect Immun 64:1614–1620
Molestina RE, Dean D, Miller RD, Ramirez JA, Summersgill JT (1998) Characterization of a strain of Chlamydia pneumoniae isolated from a coronary atheroma by analysis of the omp1 gene and biological activity in human endothelial cells. Infect Immun 66:1370–1376
Yamashita K, Ouchi K, Shirai M, Gondo T, Nakazawa T, Ito H (1998) Distribution of Chlamydia pneumoniae infection in the atherosclerotic carotid artery. Stroke 29:773–778
Danesh J, Peto R (1998) Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies. BMJ 316:1130–1132
Gupta S, Leatham EW, Carrington D, Mendall MA, Kaski JC, Camm AJ (1997) Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation 96:404–407
Gurfinkel E, Bozovich G, Daroca A, Beck E, Mautner B, for the ROXIS Study Group (1997) Randomised trial of roxithromycin in non-Q wave coronary syndromes: ROXIS pilot study. Lancet 350:404–407
Zhou YF, Guetta E, Yu ZX, Finkel T, Epstein SE (1996) Human cytomegalovirus increases modified low density lipoprotein uptake and scavenger receptor mRNA expression in vascular smooth muscle cells. J Clin Invest 98:2129–2138
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Capron, L., Wyplosz, B. (2002). Basic Mechanisms of Atherosclerosis: From Inflammation to Infection. In: Pinsky, M.R., Artigas, A., Dhainaut, JF. (eds) Coronary Circulation and Myocardial Ischemia. Update in Intensive Care Medicine, vol 32. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-57212-8_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-57212-8_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-42588-5
Online ISBN: 978-3-642-57212-8
eBook Packages: Springer Book Archive